BlackRock
TMCI icon

BlackRock’s Treace Medical Concepts TMCI Stock Holding History

BlackRock’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.49M Sell
1,380,021
-1,960,002
-59% -$5.39M ﹤0.01% 3897
2026
Q1 		$4.48M Sell
3,340,023
-71,115
-2% -$142K ﹤0.01% 3875
2025
Q4 		$8.36M Sell
3,411,138
-271,522
-7% -$1.18M ﹤0.01% 3575
2025
Q3 		$24.7M Sell
3,682,660
-83,998
-2% -$548K ﹤0.01% 2959
2025
Q2 		$22.1M Sell
3,766,658
-116,842
-3% -$761K ﹤0.01% 2961
2025
Q1 		$32.6M Buy
3,883,500
+109,402
+3% +$983K ﹤0.01% 2628
2024
Q4 		$28.1M Sell
3,774,098
-408,222
-10% -$2.73M ﹤0.01% 2824
2024
Q3 		$24.3M Buy
4,182,320
+113,654
+3% +$730K ﹤0.01% 2903
2024
Q2 		$27.1M Buy
4,068,666
+368,470
+10% +$2.98M ﹤0.01% 2798
2024
Q1 		$48.3M Buy
3,700,196
+8,295
+0.2% +$111K ﹤0.01% 2453
2023
Q4 		$47.1M Buy
3,691,901
+234,599
+7% +$2.37M ﹤0.01% 2510
2023
Q3 		$45.3M Buy
3,457,302
+336,752
+11% +$6.16M ﹤0.01% 2446
2023
Q2 		$79.8M Buy
3,120,550
+525,466
+20% +$13.6M ﹤0.01% 2198
2023
Q1 		$65.4M Buy
2,595,084
+231,028
+10% +$5.42M ﹤0.01% 2278
2022
Q4 		$54.3M Buy
2,364,056
+95,145
+4% +$2.19M ﹤0.01% 2405
2022
Q3 		$50.1M Buy
2,268,911
+425,350
+23% +$8.23M ﹤0.01% 2430
2022
Q2 		$26.4M Buy
1,843,561
+238,372
+15% +$4.02M ﹤0.01% 2930
2022
Q1 		$30.4M Buy
1,605,189
+86,363
+6% +$1.68M ﹤0.01% 2904
2021
Q4 		$28.3M Buy
1,518,826
+832,591
+121% +$17.2M ﹤0.01% 3051
2021
Q3 		$18.5M Buy
686,235
+3,894
+0.6% +$107K ﹤0.01% 3331
2021
Q2 		$21.3M Buy
+682,341
New +$21.7M ﹤0.01% 3255

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock's TMCI Position: Q2 2026 in Review

BlackRock reduced its Treace Medical Concepts (TMCI) stake by 59% in Q2 2026, selling an estimated $5.39M and leaving 1,380,021 shares worth $5.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3897.

BlackRock first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $79.8M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • BlackRock held 1,380,021 shares of Treace Medical Concepts worth $5.49M as of Q2 2026.
  • BlackRock sold 1,960,002 Treace Medical Concepts shares in Q2 2026, an estimated $5.39M.
  • Treace Medical Concepts made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3897 holding.
  • BlackRock first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • BlackRock's Treace Medical Concepts position peaked at $79.8M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.